---
figid: PMC8708448__pharmaceutics-13-02116-g004
figtitle: 'Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update
  and Prospective'
organisms:
- NA
pmcid: PMC8708448
filename: pharmaceutics-13-02116-g004.jpg
figlink: /pmc/articles/PMC8708448/figure/pharmaceutics-13-02116-f004/
number: F4
caption: Hedgehog signaling pathway and potential RNAi targets. HHN, Hedgehog N–terminal
  fragment; SMO, Smoothened; KIF7, Kinesin family member 7; SUFU, suppressor of fused
  homologue; GLI, Glioma-Associated Oncogene Homolog 1.
papertitle: 'Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update
  and Prospective.'
reftext: Yongquan Tang, et al. Pharmaceutics. 2021 Dec;13(12):2116.
year: '2021'
doi: 10.3390/pharmaceutics13122116
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords: nanoparticle | RNAi therapeutics | cancer stem cells | drug resistance
automl_pathway: 0.9608049
figid_alias: PMC8708448__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8708448__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8708448__pharmaceutics-13-02116-g004.html
  '@type': Dataset
  description: Hedgehog signaling pathway and potential RNAi targets. HHN, Hedgehog
    N–terminal fragment; SMO, Smoothened; KIF7, Kinesin family member 7; SUFU, suppressor
    of fused homologue; GLI, Glioma-Associated Oncogene Homolog 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MIR326
  - SMO
  - SMOX
  - KIF7
  - SUFU
  - GLI1
  - GLI2
  - GLI3
  - PTCH1
  - PTCH2
---
